E2022 Patch Formulation Multiple Dose Study
Clinical trial NCT01450839 · COMPLETED
Trial details
- NCT number
- NCT01450839
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2011-11-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.